Subscribe To
coherus presents data from next-generation immuno-oncology programs at 38th annual meeting of society for immunotherapy of cancer (sitc)
– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in vitro, supporting ongoing clinical development ...
November 3, 2023, 12:30 pm
coherus biosciences to participate at upcoming november investor conferences
REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) — coherus BioSciences, Inc. (“...
November 3, 2023, 12:00 am
coherus biosciences to participate at upcoming november investor conferences
REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- coherus BioSciences, Inc. (“...
November 2, 2023, 8:00 pm
coherus biosciences to report third quarter 2023 financial results on november 6, 2023
REDWOOD CITY, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — coherus BioSciences, Inc. (“...
October 30, 2023, 10:00 pm
coherus biosciences to report third quarter 2023 financial results on november 6, 2023
REDWOOD CITY, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- coherus BioSciences, Inc. (“...
October 30, 2023, 6:00 pm
Why coherus biosciences stock soared today
coherus and Chinese partner Junshi Biosciences announced U.S. FDA approval of Loqtorzi in all lines of ...
October 30, 2023, 5:43 pm
Intuitive machines stock climbs on lunar mission plan as mcdonald's edges higher ahead of results
coherus BioSciences stock CHRS, -3.65% rose 17% as the Food and Drug Administration approved its treatm...
October 30, 2023, 5:20 am
coherus announces toripalimab data at 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
— Data demonstrate preclinical potent T cell activation and differentiated mechanism of action and enhanced clinical efficacy irrespective of PD-L1 ...
October 14, 2023, 4:30 pm
Why coherus biosciences stock popped today
coherus announced it has resubmitted a biologic license application for one of its products. The FDA ha...
October 5, 2023, 4:45 pm
coherus announces three presentations at the 38th annual meeting of the society for immunotherapy of cancer (sitc)
REDWOOD CITY, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — coherus BioSciences, Inc. (...
September 27, 2023, 1:10 pm
coherus biosciences' new injector treatment for cancer patients rejected by fda
coherus BioSciences said Monday that the U.S. Food and Drug Administration rejected its regulatory subm...
September 25, 2023, 8:53 am
Why coherus biosciences stock was plunging this week
It is about to be deleted from a popular small-cap equity index. As of Monday, Sept....
September 8, 2023, 8:31 am
coherus biosciences to participate at upcoming september investor conferences
REDWOOD CITY, Calif., Sept. 01, 2023 (GLOBE NEWSWIRE) -- coherus BioSciences, Inc. (“...
September 1, 2023, 4:01 pm
Why coherus biosciences stock popped today
The immuno-oncology biotech specialist delivered stronger-than-expected revenue and earnings in Q2. coherus...
August 3, 2023, 7:43 pm
coherus biosciences, inc. (chrs) q2 2023 earnings call transcript
coherus BioSciences, Inc. (NASDAQ:CHRS ) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Com...
August 2, 2023, 11:35 pm
coherus biosciences (chrs) reports q2 loss, tops revenue estimates
coherus BioSciences (CHRS) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus...
August 2, 2023, 6:43 pm
coherus: why i am exiting, but also why you may want to hold on
Here, I discuss my reasons for exiting the stock. My reasons are more or less specific to my situation. Thus, we can agree to disagree without being t...
July 6, 2023, 12:40 pm
coherus biosciences launches biosimilar version of abbvie's blockbuster humira
coherus BioSciences said on Monday it has launched a copycat version of AbbVie's Humira in the United S...
July 3, 2023, 9:12 am
Lifshitz law pllc announces investigations of surf, neti, nex, and pten
NEW YORK, June 24, 2023 (GLOBE NEWSWIRE) — Surface Oncology, Inc. (NASDAQ: SURF) Lifshitz Law PLLC announces an investigation into possible breach o...
June 25, 2023, 12:11 am
Surface oncology stock flies on $65m stock-for-stock acquisition by coherus biosciences
Surface Oncology shares jumped by more than 16% on Friday morning after it was revealed the clinical-stage immuno-oncology (I-O) company is being acqu...
June 16, 2023, 11:01 am